Point72 Asia (Singapore) Pte. Ltd. Adicet Bio, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $379 Billion
- Q4 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 39,997 shares of ACET stock, worth $34,397. This represents 0.01% of its overall portfolio holdings.
Number of Shares
39,997
Previous 41,115
2.72%
Holding current value
$34,397
Previous $59.2 Million
35.01%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding ACET
# of Institutions
71Shares Held
59MCall Options Held
7.3KPut Options Held
39.3K-
Orbimed Advisors LLC San Diego, CA11.4MShares$9.84 Million0.3% of portfolio
-
Tang Capital Management LLC San Diego, CA8.15MShares$7.01 Million0.59% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.54MShares$6.49 Million0.12% of portfolio
-
Goldman Sachs Group Inc New York, NY3.75MShares$3.23 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$2.76 Million0.0% of portfolio
About Adicet Bio, Inc.
- Ticker ACET
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,030,800
- Market Cap $34.4M
- Description
- Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...